For the Quarter Ending March 2026
Ìý
Paracetamol Prices in APAC
- In China, the Paracetamol Price Index rose by 6.79% quarter-over-quarter, driven by export bookings and inspections.
- The average Paracetamol price for the quarter was approximately USD 2806.67/MT, reported on FOB Shanghai.
- Paracetamol Spot Price tightened in March after inspections reduced cargoes, prompting higher offers from exporters.
- Paracetamol Price Forecast suggests modest easing in early Q2 as buyers rebuild and inventories normalize.
- Paracetamol Production Cost Trend rose due to higher coal and steam tariffs, increasing conversion expenses.
- Paracetamol Demand Outlook remains firm from overseas formulators rebuilding stocks, while domestic spot buying is subdued.
- Paracetamol Price Index surged in March as environmental inspections and feedstock cost inflation tightened supply.
- Inventories at Shanghai and Ningbo contracted to eight days, prompting exporters to lift FOB quotations.
Why did the price of Paracetamol change in March 2026 in APAC?
- Environmental inspections in Jiangsu and Shandong reduced p-aminophenol line operating days, tightening finished paracetamol supply.
- Firm overseas booking activity for seasonal demand absorbed available cargoes, intensifying competition for limited shipments.
- Rising energy tariffs and higher benzene-based feedstock costs increased production expenses, supporting firmer FOB quotations.
Paracetamol Prices in Europe
- In Germany, the Paracetamol Price Index rose by 7.23% quarter-over-quarter, due to tighter spot availability.
- The average Paracetamol price for the quarter was approximately USD 2910/MT, per importers' CFR reports.
- Paracetamol Spot Price firmed in March as limited replacement cargoes tightened immediate European availability and bids.
- Paracetamol Price Forecast suggests near-term upside; importers to maintain cautious buying against longer transit times.
- Paracetamol Production Cost Trend reflected higher Asian feedstock and energy charges, lifting exporters' FOB quotations.
- Paracetamol Demand Outlook remains steady with downstream formulators replenishing safety stocks, supporting firm procurement activity.
- Suppliers cited elevated compliance testing and container dwell costs contributing to the Paracetamol Price Index.
- Inventory buffers at German toll formulators eased buying urgency, tempering volatility despite firm Paracetamol fundamentals.
Why did the price of Paracetamol change in March 2026 in Europe?
- Tighter spot availability from India and China reduced immediate offers, raising landed-duty-paid values for importers.
- Rising Asian raw material and energy costs increased exporters' FOB quotations, feeding through to higher landed costs.
- Extended container dwell times and GMP re-testing added logistical and compliance premiums, intensifying upward price pressure.
Paracetamol Prices in North America
- In the USA, the Paracetamol Price Index rose by 6.43% quarter-over-quarter, reflecting constrained import flows.
- The average Paracetamol price for the quarter was approximately USD 2951.67/MT, reflecting balanced imports and consumption.
- Paracetamol Spot Price firmed amid inventory draws, with distributors competing for limited Gulf Coast shipments.
- Paracetamol Price Forecast indicates near-term firmness as exporters trim spot allocations following post-holiday allocation shifts.
- Paracetamol Production Cost Trend rose due to higher para-aminophenol and feedstock pressures at Asian plants.
- Paracetamol Demand Outlook strengthened with late-season influenza activity and hospital front-loading boosting acute institutional purchases.
- Paracetamol Price Index increased as FDA import alerts and constrained Asian loadings tightened landed availability.
- Distributor inventory draws and steady freight left spot market liquidity limited, preventing broader price correction.
Why did the price of Paracetamol change in March 2026 in North America?
- Constrained imports from Asian suppliers reduced immediate landed availability, tightening short-term supply and lifting bids.
- Late-season influenza surge increased institutional and retail call-offs, accelerating spot buying and depleting distributor inventories.
- Rising feedstock costs plus FDA import alerts raised production costs, reducing exportable volumes and offers.
For the Quarter Ending December 2025
APAC
• In China, the Paracetamol Price Index fell by 2.4% quarter-over-quarter, reflecting oversupply and subdued exports.
• The average Paracetamol price for the quarter was approximately USD 2850.00/MT, underpinned by steady production.
• Paracetamol Spot Price remained narrow as ample inventories and muted enquiries constrained seller pricing power.
• Paracetamol Price Forecast shows limited near-term upside because balanced supply and cautious international buying persist.
• Paracetamol Production Cost Trend was stable as feedstock availability and capped energy tariffs supported margins.
• Paracetamol Demand Outlook remains cautious with routine domestic OTC demand and limited overseas restocking activity.
• Paracetamol Price Index compression partly reflected smooth logistics, unchanged export rebate, and high operating rates.
• Inventories rose modestly, pressuring offers, while eased freight and stable rebates allowed FOB adjustments comfortably.
Why did the price of Paracetamol change in December 2025 in APAC?
• Ample export-oriented supply and steady domestic output created surplus, exerting downward pressure on December prices.
• Feedstock costs remained broadly stable; para-aminophenol upticks offset by capped energy costs and unchanged tariffs.
• Improved port logistics and easing freight allowed FOB reductions, while cautious buyers limited restocking demand.
Europe
• In Germany, the Paracetamol Price Index fell by 3.47% quarter-over-quarter, reflecting eased landed cost pressures.
• The average Paracetamol price for the quarter was approximately USD 2920.00/MT, driven by freight savings.
• Paracetamol Spot Price momentum remained weak as imports increased and buyers delayed nonessential replenishment activity.
• Paracetamol Price Forecast points to limited upside because inventories remain comfortable and demand stays muted.
• Paracetamol Production Cost Trend improved slightly as raw material prices softened and energy costs stabilized.
• Paracetamol Demand Outlook is subdued with pharmacies and hospitals maintaining conservative purchasing, minimal spot orders.
• Paracetamol Price Index reflected logistical savings at German ports and competitive Asian offers repressing CFR.
• Distributor destocking and weak export inquiries amplified downward pressure on landed quotations during the month.
Why did the price of Paracetamol change in December 2025 in Europe?
• Sustained Indian and Chinese shipments increased availability, reducing landed costs and diminishing seller negotiation leverage.
• Lower freight rates and port operations at Hamburg cut logistics expenses, transmitting savings into CFR.
• Domestic demand normalized after the early-winter spike, with hospitals and wholesalers refraining from emergency restocking activity.
North America
• In the USA, the Paracetamol Price Index fell by 2.84% quarter-over-quarter, driven by Chinese oversupply.
• The average Paracetamol price for the quarter was approximately USD 2963.33/MT, per import statistics reported.
• Paracetamol Spot Price remained range-bound as steady Asian shipments and softened freight constrained landed-cost volatility.
• Paracetamol Price Forecast projects mild weakness as inventories persist and buyers delay sizable replenishments further.
• Paracetamol Production Cost Trend showed stability with phenol feedstock steady and shipping costs modestly improved.
• Paracetamol Demand Outlook indicated seasonal uplift absorbed imports, but overall offtake remained conservative and inventory-focused.
• Paracetamol Price Index dynamics reflected inventory destocking, steady exports, with distributors negotiating marginal concessions actively.
• Major Asian producers operated normally, and Gulf Coast warehouses held cover amid consistent vessel arrivals.
Why did the price of Paracetamol change in December 2025 in North America?
• Abundant Chinese and Indian shipments maintained import availability, reducing scarcity and suppressing upward price momentum.
• High US inventories and conservative replenishment from distributors limited procurement urgency, tempering short-term demand pressure.
• Stable phenol feedstock costs and lower trans-Pacific freight reduced landed-cost pressures, easing immediate seller influence.
For the Quarter Ending September 2025
North America
• In the USA, the Paracetamol Price Index fell by 7.7% quarter-over-quarter, reflecting broad import weakness.
• The average Paracetamol price for the quarter was approximately USD 3050/MT, reflecting landed cost equilibrium.
• Paracetamol Spot Price softened amid elevated inventories and cheaper China offers, pressuring the Price Index.
• Paracetamol Production Cost Trend eased after freight declines and raw material offers softened, reducing production pressure.
• Paracetamol Demand Outlook remains steady for pharmaceuticals, but destocking and seasonal lull limit immediate procurement growth.
• Paracetamol Price Forecast indicates modest softening before year-end, driven by surplus supply and muted enquiries.
• Export demand weakness and inventory overhang pressured Paracetamol Price Index despite stable U.S. port logistics.
• Supplier discipline tightened flows, yet Chinese export competition sustained downward pressure on Paracetamol CFR assessments.
Why did the price of Paracetamol change in September 2025 in North America?
• Global export offers from China weakened, lowering landed costs and translating into softer U.S. assessments.
• Inventory destocking by importers reduced spot procurement urgency, pressuring immediate spot market liquidity and prices.
• Freight rate declines and temporary tariff relief cut landed costs, amplifying downward pressure on domestic prices.
APAC
• In China, the Paracetamol Price Index fell by 7.59% quarter-over-quarter, reflecting oversupply pressure and destocking.
• The average Paracetamol price for the quarter was approximately USD 2920.00/MT, based on FOB Shanghai.
• Paracetamol Spot Price continued under pressure as destocking and weaker export inquiries reduced buyer participation.
• Paracetamol Price Forecast indicates slight further downside short term before stabilization driven by inventory normalization.
• Paracetamol Production Cost Trend eased as raw material prices moderated, offsetting logistics and energy pressures.
• Paracetamol Demand Outlook remains subdued due to weak seasonal illnesses, cautious procurement, and constrained orders.
• Paracetamol Price Index weakness was exacerbated by US tariff impacts, logistical delays, and concentrated inventories.
• Maintenance at major units tightened supply briefly, but smaller producers ramped output, sustaining inventory overhang.
Why did the price of Paracetamol change in September 2025 in APAC?
• Elevated inventories from aggressive domestic production and destocking increased available supply, forcing downward price adjustments.
• Export demand collapsed because of tariffs and trade disruptions, reducing overseas orders and depressing prices.
• Weaker downstream procurement and cautious buyers, alongside lower feedstock costs, squeezed margins and curtailed purchasing.
Europe
• In Germany, the Paracetamol Price Index fell by 6.923% quarter-over-quarter, reflecting import-led destocking and logistics
• The average Paracetamol price for the quarter was approximately USD 3025.00/MT, reflecting steady import costs
• Paracetamol Spot Price softness pressured the Paracetamol Price Index, prompting sellers to offer competitive dispatches
• Paracetamol Price Forecast suggests modest downward momentum as inventories remain ample and buyer inquiries subdued
• Paracetamol Production Cost Trend showed easing input and freight expenses, reducing cost pressures for suppliers
• Paracetamol Demand Outlook remains mixed with downstream restocking offset by conservative procurement and weak demand
• Paracetamol Price Index movements were influenced by eased port congestion and increased Indian export availability
• Inventory destocking pushed transactional offers lower, while some formulators secured coverage for early 2026 production
Why did the price of Paracetamol change in September 2025 in Europe?
• Higher import volumes from India and China increased availability, easing landed costs and pressuring prices
• Lower global freight rates and eased port congestion reduced logistics premiums, supporting Paracetamol price declines
• Downstream conservative procurement and trader destocking amid adequate inventories drove recent downward price pressure marketwide
For the Quarter Ending June 2025
North America
• Paracetamol prices in North America exhibited an upward trajectory in Q2 2025, with an average Quarter over Quarter fluctuation around 1.79%, influenced by price changes of -0.46% (April), 2.63% (May), and 1.20% (June).
• The Paracetamol Spot Price was notably pressured in April due to weak demand and cautious procurement amid U.S.-China trade tensions and tariff-induced supply shifts, which created a buyer's market.
• Persistent elevated inventories coupled with reduced ocean container bookings (down 49%) led to oversupply and sustained downward price pressure in early Q2.
• May saw a sharp price rebound driven by intense disruption in freight logistics, port congestion, and rising Peak Season Surcharges (PSSs), escalating landed costs for Paracetamol imports.
• The surge in global freight demand, especially from China, boosted both the Paracetamol Spot Price and the Paracetamol Production Cost Trend due to increased transportation expenses.
• May’s robust downstream demand from pharmaceutical and healthcare sectors intensified procurement activity, increasing safety stock levels and reinforcing firm pricing.
• Paracetamol Price Forecast for June 2025 predicted higher prices amid tightened global supply and ongoing logistical challenges, driven by elevated feedstock costs in China and supply constraints.
• June marked historic highs in Paracetamol prices, with steady demand in pharmaceuticals, food, and biofuels sectors maintaining upward price momentum.
• The Paracetamol Demand Outlook indicated sustained growth, fueled by rising self-medication trends, chronic pain management needs, and innovative formulations emphasizing reliability and quality.
• Overall, North America’s Q2 witnessed volatility but ended with a strong upward price trend, reflecting a complex interplay between supply chain disruptions, tariff policies, and resilient downstream demand.
Asia Pacific
• The APAC Paracetamol market displayed a stable to slightly fluctuating price trend in Q2 2025, averaging a moderate net change of approximately +0.76%, with prices rising 0.32% in April, 2.89% in May, and dropping 0.94% in June.
• April’s Paracetamol Spot Price in China saw improvement driven by macroeconomic factors such as Yuan depreciation and port congestions, though buyer inventories remained lean and cautious.
• A temporary surge in outbound freight activity occurred following impending U.S. tariff announcements, which increased global exporter focus on Chinese Paracetamol supplies.
• Supply-side pressures intensified in May due to rising raw material costs (para-aminophenol and acetic anhydride), environmental regulations, and manufacturing inefficiencies contributing to increased Paracetamol Production Cost Trend.
• May also experienced a surge in container shipping rates (up 27%), driven by rushed import orders before tariff reprieves ended, which strengthened supplier pricing power globally.
• The Paracetamol Demand Outlook reflected renewed global buying momentum in May, particularly from U.S. pharmaceutical companies rebuilding inventories ahead of tariff reinstatements, leading to tighter stocks.
• June reversed the prior upward trend, as Chinese domestic deflationary pressures, excess inventories, and fierce price competition forced prices downward despite temporary production shutdowns of major producers.
• Maintenance shutdowns of large manufacturers in June allowed smaller, lower-cost producers to increase supply aggressively, exacerbating oversupply risks and reinforcing intense price competition.
• Demand in June weakened due to sluggish consumer and industrial consumption domestically, coupled with overcapacity that impacted overall market sentiment and Paracetamol Spot Price negatively.
• The June 2025 scenario suggested caution with the Paracetamol Price Forecast anticipating continued downward pressure amid persistent supply surpluses and subdued demand in APAC markets.
Europe
• Europe’s Paracetamol market witnessed a steady upward trajectory in Q2 2025 with an average Quarterly fluctuation of approximately 1.05%, reflecting price changes of 0.31% (April), 2.50% (May), and 0.15% (June).
• In April, logistics disruptions from holidays, port congestion, strikes, and low Rhine water levels hampered supply, contributing to firm Paracetamol Spot Prices due to increased inbound freight costs and limited freight capacity.
• April saw cautious demand from German buyers focusing on supply security to mitigate risks from uncertain delivery schedules and price volatility.
• May’s price surge was driven by ongoing port congestion, industrial actions, and severe inland transport restrictions, which combined with reallocation of vital shipping capacity to trans-Pacific routes tightened supply and pressured prices upwards.
• The Paracetamol Production Cost Trend was influenced by rising import and transport expenses, including congestion surcharges and reduced vessel availability, pushing manufacturers to increase prices.
• Downstream demand remained robust in May, particularly from healthcare and pharmaceutical industries actively replenishing stocks against supply uncertainties, supporting a seller’s market.
• June continued the upward price momentum, supported by stable manufacturing outputs combined with an order surge and export deal influx due to buyers replenishing critically low inventories.
• Freight bottlenecks persisted in June due to congested northern ports and extended transit times from alternative routes such as the Cape of Good Hope, further inflating landed costs in Europe.
• The Paracetamol Demand Outlook in June reflected strong restocking efforts from pharmaceutical manufacturers and OTC healthcare sectors, reinforced by Germany’s improved Manufacturing PMI, signaling industrial recovery.
• Overall, Europe’s Q2 saw steady price increases underpinned by sustained demand, supply chain complexity, and logistical constraints that kept Paracetamol prices firm by quarter-end.